Shoulder Innovations reported third-quarter 2026 net revenue of $16.2 million, a 38% increase from the prior year period, driven by higher implant system sales volume and an increased average selling price. The company achieved a gross margin of 78.5% and raised its full-year 2026 net revenue guidance to a range of $68 million to $70 million, up from the previous estimate of $67 million to $69 million. Operating loss remained stable at $7.6 million as increased gross profit was offset by higher selling, general and administrative expenses and research and development investments. The company also announced the commercial launch of its N-22 humeral head implant and an exclusive partnership with ALM Ortho for additively manufactured solutions. Shoulder Innovations is a medical technology company focused on transforming shoulder surgical care through advanced implant systems.
